ArticleBlood cell therapy2025

Role of Composite Measurable Residual Disease Assessment with PET-CT and flow cytometry in Multiple Myeloma patients undergoing Autologous Transplant.

Rudra Narayan Swain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.